熱門資訊> 正文
自行车治疗学确保长期核和工业合作伙伴关系，以支持212铅放射性药物开发和商业供应
2025-12-16 14:09
- Execution of a 15-year contract including an option to renew with UK Nuclear Decommissioning Authority for access to up to 400 tonnes of reprocessed uranium (RepU), with the potential to deliver tens of thousands of doses of 212Pb every year
- Partnership with the United Kingdom National Nuclear Laboratory (UKNNL) to scale up the extraction of 228Th from RepU for onward processing into a 212Pb generator
- Agreement with SpectronRx to develop a bespoke wholly owned 212Pb generator, with initial quantities of 212Pb successfully produced
- Bicycle Therapeutics plc (NASDAQ:BCYC), a pharmaceutical compan
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
